Latest Research Report By Market Research Future (MRFR)Ophthalmic Drugs Market Research Report: By Indication (Glaucoma, Retinal Disorder, Others), Class (Antiallergy, Anti-Inflammatory, And Others), Dosage (Eye Drops, Others), Product (Prescription, OTC Drug), Distribution Channel – Global Forecast Till 2023
The Central Players Featured In The Ophthalmic Drugs Market Are: Allergan Plc,Bausch & Lomb Inc.,Genentech Inc.,Merck & Co. Inc.,Pfizer Inc.,Actavis Generics,Regeneron Pharmaceuticals Inc.,Shire Plc,Sun Pharmaceutical Industries Limited,Santen Pharmaceutical Co. Ltd.,Teva Pharmaceutical Industries Ltd.,Valeant Pharmaceuticals International,and others
Market Highlights
It Is Estimated That The Ophthalmic Drugs Market Is Expected To Grow At A CAGR 6.0% During The Forecast Period Of 2017 To 2023.
Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In the recent years, various new and existing marketers have come up with effective drugs. For instance, in November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.
A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are a few factors propelling the growth of the global ophthalmic drugs market. According to the 2017 statistics suggested by the World Health Organization (WHO), the chronic eye disease is the main cause of vision loss, globally.
However, the high cost associated with a diagnosis of eye diseases, side effects of available treatment options, and lack of healthcare insurance may hamper the growth of the market.
The changes in lifestyle and environment have raised the incidence of eye disorders that require medicines to treat the situation. Reports that gauge the medical device industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects
The influence of factors such as increasing awareness of eye disease and increased research funding in ophthalmology is expected to motivate the ophthalmic drugs market in the coming years. The increased level of research into drugs for ophthalmic application is greatly inspiring the market for ophthalmic drugs in the forecast period. Moreover, the increased aging population is predicted to create additional opportunities for development in the approaching period.
Fill Out Details To Receive FREE Sample Here: https://www.marketresearchfuture.com/sample_request/5753
Industry Updates
February 2019- Bausch + Lomb, a leading eye health company, announced that it had received FDA approval for LOTEMAX SM (loteprednol etabonate ophthalmic gel). The new gel formulation is intended to treat postoperative inflammation and pain following ocular surgery.
Segmental Analysis
The segmentation of the ophthalmic drugs market is carried out on the basis of drug class, product, indication, type of dosage, and distribution channel. Based on indication, the ophthalmic drugs market is segmented into retinal disorders, inflammation/infection, glaucoma, dry eye, uveitis, allergies, and others. The segmentation of the market for ophthalmic drugs based on drug class comprises of antiglaucoma, anti-inflammatory, antiallergy, anti-VEGF agents, and others.
The anti-inflammatory segment is additionally segmented into steroidal drugs and nonsteroidal drugs. Based on the dosage, the ophthalmic drugs market is segmented into ointments, eye drops, capsules and tablets, eye solutions, and gels. By product, the ophthalmic drugs market is segmented into OTC drugs and prescription drugs. Based on the distribution channel, the ophthalmic drugs market is segmented into online pharmacies, drug stores, hospital pharmacies, and others.
Detailed Regional Analysis
The examination of the regions in the ophthalmic drug market consists of regions such as the Middle East, Africa, Europe, America, and the Asia Pacific. The Americas region controls the ophthalmic drugs market due to the incidence of the patient population, intensifying prevalence of eye diseases, sophisticated technology, soaring healthcare expenditure, and the existence of the leading companies.
The European region controls the next position in the ophthalmic drugs market. It is anticipated that the government backing towards research and development spending, growing competition among marketers, and adjustments in reimbursement policies in healthcare are expected to guide the European market in the coming years.
The Asia Pacific region is the quickest mounting ophthalmic drugs market due to the presence of an enormous patient pool, growing demand, and expansion of healthcare technology globally. Moreover, the Middle East and Africa region control the minimum share of the ophthalmic drugs market owing to low growth, deficiency of technical knowledge, and deprived medical facilities.
Competitive Analysis
The progress of the market is expected to capture increased momentum in the coming years primarily due to the presence of conducive government policies. The growth turnaround in the market is expected to activate new opportunities for expansion of the market. The improvements in various domestic economies are expected to motivate the development of the market in the upcoming period. The accessibility to key tactical opportunities leading to consequent stabilization of inflation is anticipated to create promising openings for expansion in the coming years.
In the coming years, the influence exerted by relatively high-income levels in nations around the world and the potential gains observed to some of the currencies in the world is expected to reinforce the evolution of the market in the forecast period. A considerable rise in the number of investors in the market is projected to create an advantageous scenario for the progress of the market in the forecast period.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Ophthalmic Drugs Market, By Treatment
6.1 Introduction
6.2 Drug Class
6.2.1 Market Estimates & Forecast, 2017–2023
6.3 Devices
6.3.1 Market Estimates & Forecast, 2017–2023
6.4 Others
6.4.1 Market Estimates & Forecast, 2017–2023
Chapter 7. Global Ophthalmic Drugs Market, By End-User
7.1 Introduction
7.2 Hospitals
7.2.1 Market Estimates & Forecast, 2017–2023
7.3 Clinics
7.3.1 Market Estimates & Forecast, 2017–2023
7.4 Diagnostic Centers
7.4.1 Market Estimates & Forecast, 2017–2023
7.5 Drug Stores
7.5.1 Market Estimates & Forecast, 2017–2023
7.6 Pharmacies
7.6.1 Market Estimates & Forecast, 2017–2023
7.7 Others
7.7.1 Market Estimates & Forecast, 2017–2023
Chapter 8. Global Ophthalmic Drugs Market, By Region
Chapter 9 Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
9.3.1 Key Developments
Chapter 10 Company Profiles
10.1 Actavis Generics
10.1.1 Company Overview
10.1.2 Types Overview
10.1.3 Financials
10.1.4 SWOT Analysis
10.2 Allergan Plc
10.2.1 Company Overview
10.2.2 Types Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis Others……….
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s View Point
11.1.2 Unmet Needs Of The Market
11.2 Key Companies To Watch
11.3 Prediction Of The Ophthalmic Drugs Industry
Chapter 12 Appendix
LIST OF TABLES
Table 1 Ophthalmic Drugs Industry Synopsis, 2017–2023
Table 2 Ophthalmic Drugs Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Ophthalmic Drugs Market, By Region, 2017–2023, (USD Million)
Table 4 Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)
Table 5 Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)
Table 6 Ophthalmic Drugs Market, By Type Of Dosage, 2017–2023, (USD Million)
Table 7 Ophthalmic Drugs Market, By Product, 2017–2023, (USD Million)
Table 8 Ophthalmic Drugs Market, By Distribution Channel, 2017–2023, (USD Million)
Table 9 North America Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)
Table 10 North America Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)
Table 11 North America Ophthalmic Drugs Market, By Type Of Dosage, 2017–2023, (USD Million)
Table 12 North America Ophthalmic Drugs Market, By Product, 2017–2023, (USD Million)
Table 13 North America Ophthalmic Drugs Market, By Distribution Channel, 2017–2023, (USD Million)
Table 14 U.S. Ophthalmic Drugs Market, By Indication, 2017–2023, (USD Million)
Table 15 U.S. Ophthalmic Drugs Market, By Drug Class, 2017–2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Ophthalmic Drugs Market
Figure 3 Segmentation Market Dynamics For Ophthalmic Drugs Market
Figure 4 Global Ophthalmic Drugs Market Share, By Indication 2016
Figure 5 Global Ophthalmic Drugs Market Share, By Drug Class 2016
Figure 6 Global Ophthalmic Drugs Market Share, By Type Of Dosage 2016
Figure 7 Global Ophthalmic Drugs Market Share, By Product 2016
Figure 8 Global Ophthalmic Drugs Market Share, By Distribution Channel 2016
Figure 9 North America Ophthalmic Drugs Market Share, By Country, 2016
Figure 10 Europe Ophthalmic Drugs Market Share, By Country, 2016
Figure 11 Asia Pacific Ophthalmic Drugs Market Share, By Country, 2016
Figure 12 Middle East & Africa Ophthalmic Drugs Market Share, By Country, 2016
Figure 13 Global Ophthalmic Drugs Market: Company Share Analysis, 2016 (%)
Figure 14 Actavis Generics: Key Financials
Figure 15 Actavis Generics: Segmental Revenue
Continued…
BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
